Cinacalcet drug classification?

What class does cinacalcet belong to?

Cinacalcet is classified as a calcimimetic medication. It works by increasing the sensitivity of the calcium-sensing receptors in the parathyroid gland to extracellular calcium, which helps lower parathyroid hormone (PTH) levels and reduces serum calcium in certain conditions.

Is cinacalcet a hormone or a parathyroid drug?

Cinacalcet is not a hormone replacement. It is an endocrine-targeting drug that acts on the parathyroid calcium-sensing system. Clinically, it is used for disorders involving abnormal PTH secretion and calcium levels.

What medical conditions is cinacalcet typically used for?

Cinacalcet is used in settings such as:
- Secondary hyperparathyroidism (commonly in patients with chronic kidney disease on dialysis)
- Hypercalcemia associated with primary hyperparathyroidism
- Hypercalcemia in patients with parathyroid carcinoma

Why is its “calcimimetic” classification important?

Its calcimimetic mechanism explains why it can lower PTH and reduce calcium levels without directly replacing hormones. By modulating the calcium-sensing receptors, it changes the gland’s response to calcium.

How does cinacalcet compare with related calcium/PTH drugs?

Cinacalcet’s distinguishing feature is that it is a receptor modulator (calcimimetic). That places it in a different mechanistic category than drugs that:
- Replace active vitamin D (which can raise calcium and PTH in some contexts)
- Directly suppress PTH through other pathways
- Provide calcium supplementation or other metabolic interventions

Sources

• https://en.wikipedia.org/wiki/Cinacalcet